Health News Releases

  • Today December 20
April 08, 2020 13:54
St. Luke’s University Health Network One of the First in the World to Pilot Masimo SafetyNet™, a Remote Patient Management Solution, to Aid Hospitalized COVID-19 Patients
Masimo (NASDAQ: MASI) announced today that St. Luke’s University Health Network (SLUHN) is one of the first institutions worldwide to use Masimo SafetyNet™ to monitor in-hospital patients, as the netw
April 08, 2020 12:56
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) to develop a potential plasma-deri
April 08, 2020 09:00
Morinaga Milk Obtains FDA GRAS Approval for Its Probiotic Bifidobacterium longum BB536 in Infant Formula
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received FDA GRAS (Generall
April 07, 2020 16:18
LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors
LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) 2061 for SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation fact
April 03, 2020 13:00
MAK's Oracle Water System Represents Device for Preventing COVID-19
“As it is harmless, I readily clean my hands using ‘Oracle Water’ after returning home, instead of other hand-detergents,” said a citizen of Daegu who was receiving the antiseptic solution at a commun
April 03, 2020 11:59
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To creat
April 02, 2020 14:11
EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-Treated COVID-19 Patients from the SISCO Study
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced initial preliminary findings from the Papa Giovanni XXIII Hospital sponsored SISCO (Siltuximab In
April 01, 2020 15:29
Takeda Adopts Executive Compensation Recoupment Policy
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced that its Board of Directors approved an executive compensation recoupment policy (“clawback policy”). The adoptio
April 01, 2020 13:04
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) in Combination with CHP (Cyclophosphamide, Doxorubicin and Prednisone) for Treatment of Adult Patients with Previously Untreated Systemic Anaplastic Large Cell Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) granted a positive
March 31, 2020 13:57
Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT™ Platform and Acticule Infectious Disease Platform
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs including but not limited to infectious, orphan and
March 30, 2020 11:43
DeltaTrak Announces New Non-Contact Forehead Infrared Thermometer to Aid in Coronavirus Prevention
DeltaTrak®, a leading innovator of cold chain management and temperature monitoring solutions, announces the immediate availability of the new Model 15004 Non-Contact Forehead Infrared Thermometer tha
Oracle Water, produced with Oracle Water System which is a powerful epidemics prevention solution de
March 30, 2020 10:13
MAK's Oracle Water with Outstanding Cleansing and Sterilizing Power Demonstrates Effect of Preventing COVID-19
‘Oracle Water’, produced with Oracle Water System which is a powerful epidemics prevention solution developed by MAK, demonstrated the remarkable effect of preventing COVID-19. Oracle Water was beg
March 30, 2020 09:55
Siemens Energy Korea relocates the office building to Chungjeong-ro
Siemens Energy Korea (Siemens Energy Ltd·SEL) said on March 30 that it relocate the office building to the Poongsan Building in Chungjeong-ro, Seoul. With the relocation, they announced its launch as
March 27, 2020 13:50
ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients
Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin
March 26, 2020 14:13
Multi-Lingual Support From the Global MediXchange of Combating COVID-19 (GMCC) Programme to Further Enable Sharing Among Medical Personnel Worldwide
Over 440 medical institutions from 104 countries and regions have applied to learn and share experiences in battling COVID-19 through the International Medical Expert Communication Platform. The Handb
March 26, 2020 10:29
Tanner Pharma Group Announces LEUKINE EMERGENCY ACCESS PROGRAM (LEAP) to Provide Increased International Access to LEUKINE® (sargramostim)
Tanner Pharma Group today announced they are expanding their program by which the company provides access to LEUKINE® (sargramostim) in international markets. LEUKINE®, approved by the US FDA in 1991
March 25, 2020 15:31
Masimo and University Hospitals Jointly Announce Masimo SafetyNet™, a New Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts
Masimo (NASDAQ: MASI) and University Hospitals (UH), one of the largest health systems in Northeast Ohio, today jointly announced Masimo SafetyNet™, an innovative, economically scalable patient manage
March 25, 2020 14:26
In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic
Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow® licenses available for no additional charge to ho
March 24, 2020 17:26
ResMed Statement on COVID-19
ResMed (NYSE: RMD) (ASX: RMD) has released the following statement from CEO Mick Farrell regarding the evolving coronavirus disease (COVID-19) outbreak: “As a global leader in respiratory medicine,
March 23, 2020 11:53
Genomics Company Lucence Develops Viral Sample Collection Medical Device for COVID-19 Diagnosis and Surveillance
Molecular diagnostics company Lucence announced today the development of the SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) kit, a sample collection medical device to f
March 23, 2020 11:07
ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that Health Canada has approved CABENUVA, the first and
March 19, 2020 11:40
EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy Announce Initiation of an Observational Case-control Study of Siltuximab in Patients with COVID-19 who have Developed Serious Respiratory Complications
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced the initiation of the Papa Giovanni XXIII Hospital sponsored study of siltuximab, an interleukin (
March 19, 2020 11:12
Doxy.me Removes Telemedicine Barriers
Doxy.me, a free, secure telemedicine solution, stands ready to meet increased demand for a simple, convenient way for healthcare providers to meet with their patients remotely, promising to improve th
March 18, 2020 17:32
Chinese Hospitals use 3D Safety Goggles For Protection
Recently, a large safeguard instrument manufacturing enterprise in China used 200 Flashforge 3D printer Guider2 for 3D printing safety goggle production. The daily output of 3D printing safety goggles
March 18, 2020 17:06
The Lancet publishes papers from two studies of Takeda’s dengue vaccine candidate
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that The Lancet published two papers related to Takeda’s dengue vaccine candidate (TAK-003), reporting on results f
25 per page50 per page75 per page100 per page